Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 4.99 Delayed Data As of Aug 18 |  -0.16 / -3.11%Today’s Change | 4.84 Today|||52-Week Range 7.88 | -6.73% Year-to-Date |
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Cooper Laurence James Neil Chief Executive Officer |  Sale | 5/05/2017 | 132,000 | $7.12 | $939.8K | -29.92% |
Belbel Caesar J | Sale | 12/31/2016 | 21,667 | $5.35 | $115.9K | -8.78% |
Lebel Francois /ziopharm/ Executive Vice President-Research & Development | Sale | 12/31/2016 | 21,667 | $5.35 | $115.9K | -8.78% |
Belbel Caesar J | Sale | 6/01/2017 | 16,666 | $6.11 | $101.8K | -18.33% |
Brennan Murray F Director |  Buy | 11/25/2016 | 15,000 | $6.49 | $97.4K | -30.89% |
Brennan Murray F Director | Sale | 11/25/2016 | 13,483 | $7.22 | $97.3K | -30.89% |
Cooper Laurence James Neil Chief Executive Officer | Sale | 12/31/2016 | 17,292 | $5.35 | $92.5K | -8.78% |
Fowler Wyche Jr Director | Sale | 6/12/2017 | 13,980 | $5.47 | $76.5K | -8.78% |
Weiser Michael Director | Sale | 6/12/2017 | 13,300 | $5.47 | $72.8K | -8.78% |
Brennan Murray F Director | Sale | 6/12/2017 | 13,300 | $5.47 | $72.8K | -8.78% |
